An analysis of the 2022 DAWN data presents: (1) nationally representative weighted estimates of all drug-related emergency department (ED) visits, (2) nationally representative weighted estimates of the top substances involved in drug-related ED visits, including rates by race and ethnicity; (3) nationally representative weighted estimates of opioid-related ED visits...
Search Results
An analysis of final 2021 DAWN data presents: (1) nationally representative weighted estimates, including percent and unadjusted rates per 100,000, for all drug-related ED visits, (2) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (3) the assessment of monthly trends and drugs involved in polysubstance...
Preliminary Findings from Drug-Related Emergency Department Visits, 2021. An analysis of 2021 preliminary data presents (1) nationally representative weighted estimates for the top five drugs in drug-related ED visits, (2) the assessment of monthly trends and drugs involved in polysubstance ED visits in a subset of sentinel hospitals, and (3)...
Read key findings from the 2020 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment by age group. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. Unlike other NSDUH Annual National Reports, the 2020 report has no comparisons...
Use this summary report to properly interpret 2020 NSDUH estimates of substance use and mental health issues. The report accompanies the annual detailed tables and covers overall methodology, key definitions for measures and terms used in 2020 NSDUH reports and tables, and selected analyses of the measures and how they...
These are the 2018-2019 state estimates - in thousands format. There are Excel, CSV, and PDF formats.
P-value tables to compare substate estimates within and across states for 2018-2019.
The Behavioral Health Barometer: United States, Volume 6: Indicators as measured through the 2019 National Survey on Drug Use and Health and the National Survey of Substance Abuse Treatment Services, is one of a series of national, regional, and state reports that provide a snapshot of substance use and mental...
These are behavioral health reports for each of the ten HHS regions of the United States. Each report utilizes data from the National Survey on Drug Use and Health (NSDUH), collected annually. The topics addressed in the reports include youth substance use, youth mental health and treatment, adult mental health...
This is a behavioral health report for HHS Region I of the United States and utilizes data from the National Survey on Drug Use and Health (NSDUH) and the National Survey of Substance Abuse Treatment (N-SSATS), collected annually. The topics addressed in the reports include youth substance use, youth mental...
These state profiles include data from facilities that reported to N-SSATS for the survey reference date March 29, 2019. The N-SSATS collects data on the location, characteristics, services offered, and number of clients (collected every other year) in treatment at alcohol and drug abuse treatment facilities (public and private) throughout...
Read key findings from the 2019 National Survey on Drug Use and Health (NSDUH) on substance use, mental health, and treatment by age group. Metrics in the report cover the civilian, noninstitutionalized US population ages 12 and older. The report covers both current conditions and trends over time.
Along with...
Get detailed national estimates from the 2018 and 2019 National Surveys on Drug Use and Health (NSDUH). The tables provide comprehensive statistics on substance use, mental health, and treatment in the United States. Longer-term trends are also available for select indicators.
The tables are based on the NSDUH survey, which...
National maps showing 2016-2018 estimates for the substate regions ranked from lowest to highest for each measure and divided into 7 categories.
Prevalence estimates for 15 measures of substance use and mental illness are provided along with 95% confidence intervals for persons aged 12 or older for the substance use measures, persons aged 18 or older for the mental illness measures, and persons aged 12-20 for one alcohol measure.